Intraosseous Infusion of Unrelated Cord Blood Grafts
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
- Status
- TERMINATED
- Phase
- PHASE1
Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Iron Overload in Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)
- Status
- COMPLETED
- Phase
- PHASE1
GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Collecting and Storing Tissue From Young Patients With Cancer
- Status
- COMPLETED
- Phase
- N/A